Immunization

Seeing the Possible: A Conversation with CDC Director Robert Redfield

April 30, 2019

In March 2018, Robert R. Redfield became the 18th director of CDC, bringing to the role more than 30 years of experience as a public health leader engaged in the clinical research and care of viral infections and infectious diseases, especially HIV. Since then, HHS and President Trump have announced an ambitious plan to end HIV in America, a cause which Redfield considers a prominent part of his life’s work. But public health challenges remain, including the opioid epidemic and anti-vaccine movement. In this wide-ranging conversation, Redfield shares insights into how his own personal experiences have shaped his priorities as CDC director, the importance of improved communication around vaccine education, CDC’s strategy to end HIV transmission, and how the agency plans to support states and territories as they address the opioid epidemic and other public health challenges.Read More »

Policy Approaches to Containing Antimicrobial Resistance

June 21, 2018

Antimicrobial resistance is a growing threat in the United States and containing its spread through action when even a single case of an antimicrobial resistant bacteria is identified is a priority public health strategy. In this episode, we will hear national and state perspectives on the prevention and containment of unusually resistant bacteria. The co-author of the April 2018 CDC Vital Signs report on containing unusual resistance provides an overview of the CDC strategy and Nebraska state health leadership discusses policy approaches to preventing and containing antimicrobial resistance.Read More »

See additional content »